tiprankstipranks
Trending News
More News >
Worldwide Healthcare Trust PLC GBP (GB:WWH)
LSE:WWH

Worldwide Healthcare Trust PLC GBP (WWH) AI Stock Analysis

Compare
16 Followers

Top Page

GB:WWH

Worldwide Healthcare Trust PLC GBP

(LSE:WWH)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
,
Neutral 54 (OpenAI - 5.2)
,
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
342.00 p
â–¼(-9.04% Downside)
Action:ReiteratedDate:12/30/25
The score is primarily constrained by volatile profitability and inconsistent cash flow, despite a strong, low-debt balance sheet. Technicals are moderately constructive over the longer term but mixed in the near term, and valuation is less compelling due to negative earnings and a modest dividend. Corporate events are slightly supportive but not a major driver.
Positive Factors
Conservative balance sheet
Low leverage and a sizable equity base provide durable financial flexibility for an investment trust: it can withstand sector drawdowns, hold positions through cycles, pursue opportunistic purchases, and avoid forced asset sales, supporting long-term capital preservation.
Diversified healthcare mandate
A diversified global healthcare portfolio and long-term investment mandate reduce single-name or subsector concentration risk. Structural demand for healthcare innovation and services supports multi-year growth opportunities, making the trust’s strategy resilient across cycles.
Regulatory/ NAV stability updates
Confirmations of regulatory compliance and a stable NAV are structurally supportive for investor confidence and governance. They lower operational/legal tail risk and help maintain access to capital and continuity of strategy over multi-quarter horizons.
Negative Factors
Earnings volatility
Large swings in annual investment returns undermine predictability of the trust’s long-term capital growth. Persistent volatility complicates planning for distributions, reinvestment, and performance targets, making expected shareholder returns less reliable over 2-6 months.
Weak cash generation
Inconsistent and sometimes negative operating cash flow indicates accounting gains don’t reliably convert to spendable cash. For an investment trust, weak cash limits ability to fund dividends, cover fees, or buybacks without realizing assets, raising structural liquidity risk.
Negative return on equity
A negative ROE signals capital destruction in the latest period. If losses persist or recur, the trust’s equity base and ability to generate long-term capital growth could be eroded, weakening its core proposition to investors over multiple quarters.

Worldwide Healthcare Trust PLC GBP (WWH) vs. iShares MSCI United Kingdom ETF (EWC)

Worldwide Healthcare Trust PLC GBP Business Overview & Revenue Model

Company DescriptionWorldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.
How the Company Makes MoneyWorldwide Healthcare Trust PLC does not generate operating revenue from selling products or services; it is an investment company. It makes money primarily through (1) capital appreciation: increases in the market value of its portfolio holdings; (2) investment income: dividends and other distributions received from portfolio companies; and (3) potentially other portfolio-related income such as interest on cash or fixed-income holdings if held (specifics not available: null). Returns are realized when the trust sells investments at a gain and when it receives dividends from underlying holdings. The trust’s ability to deliver shareholder returns is influenced by portfolio performance and market conditions in the healthcare sector, as well as the trust’s use of expenses and fees (e.g., management fees and operating costs) that reduce net returns to shareholders. Information on any significant partnerships or strategic commercial agreements is not available: null.

Worldwide Healthcare Trust PLC GBP Financial Statement Overview

Summary
Balance sheet strength is a key positive (low leverage and sizable equity base), but overall financial quality is held back by highly volatile earnings (swinging to a large loss in 2025) and inconsistent/weak cash generation, including negative operating cash flow in 2025.
Income Statement
38
Negative
Earnings and revenue have been highly volatile: the company swung from strong profitability in 2024 (net income of ~£201m) to a sizable loss in 2025 (net loss of ~£210m) alongside a sharp revenue decline (revenue growth rate of about -181%). Profitability was also inconsistent across prior years (losses in 2022 and 2023, strong profits in 2020–2021). While margins appear high in several years, the underlying direction is unstable, reducing confidence in earnings quality and predictability.
Balance Sheet
82
Very Positive
The balance sheet looks conservatively financed with low leverage across the period (debt-to-equity roughly ~0.02–0.10, and ~0.04 in 2025) and a large equity base (about £1.68bn in 2025). Total debt is modest (~£68m in 2025) relative to assets (~£1.78bn). The main weakness is the recent negative return on equity in 2025 (about -12.5%), reflecting the loss year rather than balance-sheet stress.
Cash Flow
34
Negative
Cash generation has been inconsistent and sometimes negative. Operating cash flow turned negative in 2025 (about -£1.5m) and was also materially negative in 2022, despite positive operating cash flow in 2023–2024. Free cash flow follows the same pattern and shows a steep decline in 2025 (growth around -79%). Overall, cash flow coverage versus reported profits appears weak in profitable years (very low operating cash flow relative to net income), raising questions about how reliably accounting gains are converting to cash.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue-138.80M-198.06M235.19M-2.23M-132.47M484.37M
Gross Profit51.70M-205.14M208.14M34.33M-132.67M536.51M
EBITDA-153.50M-209.17M0.0015.63M-130.72M486.20M
Net Income-168.47M-209.77M201.16M-8.79M-141.53M477.02M
Balance Sheet
Total Assets1.52B1.78B2.19B2.25B2.42B2.48B
Cash, Cash Equivalents and Short-Term Investments31.27M93.58M73.80M58.92M26.59M29.59M
Total Debt0.0068.07M68.94M55.93M113.60M49.90M
Total Liabilities74.17M97.39M112.79M99.21M153.22M101.24M
Stockholders Equity1.44B1.68B2.08B2.15B2.27B2.38B
Cash Flow
Free Cash Flow-3.92M-1.54M2.26M5.39M-13.33M931.00K
Operating Cash Flow-3.92M-1.54M2.26M5.39M-13.33M931.00K
Investing Cash Flow430.98M223.38M279.14M197.24M-82.68M-225.28M
Financing Cash Flow-365.10M-201.18M-279.59M-112.58M30.11M363.85M

Worldwide Healthcare Trust PLC GBP Technical Analysis

Technical Analysis Sentiment
Negative
Last Price376.00
Price Trends
50DMA
359.03
Negative
100DMA
367.26
Negative
200DMA
344.30
Negative
Market Momentum
MACD
-6.16
Positive
RSI
27.98
Positive
STOCH
28.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:WWH, the sentiment is Negative. The current price of 376 is above the 20-day moving average (MA) of 347.77, above the 50-day MA of 359.03, and above the 200-day MA of 344.30, indicating a bearish trend. The MACD of -6.16 indicates Positive momentum. The RSI at 27.98 is Positive, neither overbought nor oversold. The STOCH value of 28.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:WWH.

Worldwide Healthcare Trust PLC GBP Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
£802.15M2.308.81%―11.00%―
54
Neutral
―8.06-9.17%0.63%-156.60%-180.02%
52
Neutral
£15.38M-2.82-16.69%―30.40%23.48%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
£459.38M8.097.16%――33.10%
44
Neutral
£71.85M1.56-12.24%――-600.00%
43
Neutral
£9.64M-2.08-14.62%―-9.22%-386.93%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:WWH
Worldwide Healthcare Trust PLC GBP
335.00
27.27
8.86%
GB:GROW
Molten Ventures
464.80
181.30
63.95%
GB:FIPP
Frontier IP
12.75
-11.75
-47.96%
GB:IPO
IP Group plc
52.00
7.85
17.78%
GB:EMVC
NetScientific
55.00
14.00
34.15%
GB:ANIC
Agronomics
6.80
-0.40
-5.56%

Worldwide Healthcare Trust PLC GBP Corporate Events

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Tightens Free Float with New Share Buyback
Neutral
Mar 13, 2026

Worldwide Healthcare Trust PLC, a specialist investment trust focused on global healthcare equities, continues to actively manage its capital structure through share buybacks. The company invests in a diversified range of healthcare securities, offering shareholders targeted exposure to the sector while seeking to enhance returns and manage its share price discount.

The trust repurchased 500,000 ordinary shares at 339.65 pence each, which will be held in treasury rather than cancelled. Following this transaction, treasury shares rose to 227,472,783, leaving 374,192,417 voting shares in issue, a figure shareholders must now use when assessing disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £355.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Worldwide Healthcare Trust Publishes February 2026 Monthly Fact Sheet
Neutral
Mar 12, 2026

Worldwide Healthcare Trust PLC, a UK-based investment trust specialising in global healthcare investments, continues to offer diversified exposure to the pharmaceutical, biotechnology and broader healthcare sectors for institutional and retail investors. The trust is managed with a focus on capturing long-term growth and innovation across international healthcare markets.

The company announced that its monthly fact sheet for 28 February 2026 will shortly be available on its website, providing updated portfolio and performance information to shareholders and potential investors. This regular disclosure supports transparency and allows stakeholders to monitor the trust’s positioning and results in the context of evolving healthcare and capital markets.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Tightens Free Float with 1 Million-Share Buyback
Positive
Mar 11, 2026

Worldwide Healthcare Trust PLC has repurchased 1,000,000 of its own ordinary shares at 343.79 pence per share under an existing buyback authority, with the shares to be held in treasury. Following this transaction, the company now holds 226,972,783 shares in treasury, leaving 374,692,417 voting shares in issue, a figure shareholders can use to assess disclosure obligations under UK transparency rules.

The updated capital structure may support the trust’s share price by reducing the free float and can signal active capital management aimed at enhancing shareholder value. The change in voting rights is also relevant for institutional investors monitoring their ownership thresholds and regulatory reporting requirements.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Buys Back 500,000 Shares for Treasury
Neutral
Mar 6, 2026

Worldwide Healthcare Trust PLC has executed a market purchase of 500,000 ordinary shares at 344.64 pence per share under its existing buyback authority, and the repurchased shares will be held in treasury. Following this transaction, the company holds 225,972,783 shares in treasury, with 601,665,200 shares in issue and 375,692,417 voting rights now forming the reference figure for shareholder disclosure obligations under FCA rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Adjusts Voting Share Capital After Buyback
Neutral
Mar 4, 2026

Worldwide Healthcare Trust PLC has executed a market buyback of 1,750,000 ordinary shares at 352.21 pence per share under its existing authority, with the repurchased shares to be held in treasury. Following this transaction, the trust now holds 225,472,783 shares in treasury, leaving 376,192,417 voting shares in issue, a figure shareholders should use when assessing disclosure obligations under UK transparency rules.

The adjustment to the company’s treasury and voting share counts may influence metrics such as earnings per share and net asset value per share, while also affecting investor calculations of ownership thresholds. By continuing to use share buybacks, the trust signals ongoing capital management activity that can impact liquidity, share price support, and regulatory reporting for its stakeholders.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Regulatory Filings and Compliance
Worldwide Healthcare Trust Updates Total Voting Rights and Share Capital
Neutral
Mar 2, 2026

Worldwide Healthcare Trust PLC has reported that, as at 28 February 2026, its issued share capital comprises 601,665,200 ordinary shares of 2.5p each, of which 223,722,783 are held in treasury, leaving 377,942,417 voting rights in issue. The updated voting rights figure provides the reference denominator investors must use to assess and disclose changes in their shareholdings under UK transparency rules, helping maintain accurate market reporting and regulatory compliance.

This clarification of the trust’s capital and voting structure has implications for shareholders tracking their notifiable interest thresholds and for institutional investors managing governance positions. By reaffirming the number of voting rights, the company supports transparent ownership disclosure in the listed investment trust sector, which can aid market participants in monitoring influence and assessing liquidity dynamics.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Boosts Treasury Stock with Latest Share Buyback
Positive
Feb 27, 2026

Worldwide Healthcare Trust PLC has executed a buyback of 980,163 ordinary shares at 356 pence each under its existing authority to repurchase up to 61,086,622 shares. The repurchased shares will be held in treasury, increasing the treasury holding to 223,722,783 shares and reducing the effective free float.

Following this transaction, the trust now has 601,665,200 ordinary shares in issue, with 377,942,417 voting rights remaining in the market. The updated voting-rights figure provides a new reference denominator for shareholders assessing disclosure obligations under the FCA’s transparency rules and may slightly enhance net asset value per share over time.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Expands Treasury Stock Through Share Buyback
Neutral
Feb 25, 2026

Worldwide Healthcare Trust PLC has continued its share buyback programme, purchasing 1,375,000 ordinary shares at 356.98 pence each for holding in treasury. The transaction forms part of the authority granted by shareholders in October 2025, allowing the company to repurchase up to 61,086,622 shares in the market.

Following this latest buyback, the trust now holds 222,742,620 shares in treasury, with 601,665,200 ordinary shares in issue and 378,922,580 voting rights outstanding. The updated voting rights figure provides a new denominator for shareholders when assessing disclosure thresholds under the FCA’s transparency rules, and reflects the ongoing use of buybacks as a capital management tool.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Boosts Treasury Stock With New Share Buyback
Positive
Feb 20, 2026

Worldwide Healthcare Trust PLC has executed a share buyback, purchasing 830,000 ordinary shares at 357.49 pence each, which will be held in treasury. The move is part of an ongoing authority to repurchase shares, potentially supporting the share price and capital management strategy.

Following this transaction, the trust now holds 221,367,620 shares in treasury and has 601,665,200 shares in issue, resulting in 380,297,580 voting rights. The updated voting rights figure provides a new denominator for shareholders assessing disclosure obligations under the FCA’s transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Buys Back Shares and Updates Voting Rights
Positive
Feb 18, 2026

Worldwide Healthcare Trust PLC has continued to execute its share buyback programme, purchasing 748,000 ordinary shares at 355.21 pence each, which will be held in treasury. This move reduces the free float and is typically intended to enhance net asset value per share and support the share price for existing investors.

Following the latest transaction, the trust now holds 220,537,620 shares in treasury and has 601,665,200 ordinary shares in issue, resulting in 381,127,580 voting rights. The updated voting rights figure provides the new denominator for shareholders to assess whether they must disclose holdings under the FCA’s transparency rules, potentially affecting reporting obligations for larger investors.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Boosts Treasury Stock with New Share Buyback
Positive
Feb 13, 2026

Worldwide Healthcare Trust PLC, a specialist investment trust targeting global healthcare assets, has executed another share buyback as part of its capital management strategy. The company invests across pharmaceuticals, biotechnology, medical technology, and related healthcare services, offering shareholders focused exposure to the sector.

The trust repurchased 850,000 ordinary shares at 352.06 pence each, to be held in treasury, increasing its treasury holdings to 219,789,620 shares. Following this transaction, total shares in issue stand at 601,665,200, with 381,875,580 voting rights, a key reference figure for investors monitoring their disclosure thresholds under FCA transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Financial Disclosures
Worldwide Healthcare Trust Publishes January 2026 Monthly Fact Sheet
Neutral
Feb 12, 2026

Worldwide Healthcare Trust PLC has released its monthly fact sheet for 31 January 2026, providing updated portfolio and performance information for investors in its global healthcare-focused investment trust. The document will be available on the company’s website, supporting transparency and allowing shareholders and market participants to review the latest data on the trust’s positioning and market exposure.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Increases Treasury Stock After Share Buyback
Neutral
Feb 11, 2026

Worldwide Healthcare Trust PLC, a UK-listed investment trust specialising in global healthcare investments, has continued to actively manage its capital structure through share buybacks. The company focuses on providing diversified exposure to pharmaceuticals, biotechnology, medical devices and broader healthcare services for its investors.

The trust repurchased 600,000 ordinary shares at 354.39 pence each for holding in treasury, under the authority to buy back up to 61,086,622 shares. Following this transaction, treasury shares rose to 218,939,620, leaving 601,665,200 shares in issue and 382,725,580 voting rights, a figure shareholders must now use when assessing disclosure obligations under FCA transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Buys Back More Shares, Updates Voting Rights
Positive
Feb 6, 2026

Worldwide Healthcare Trust PLC has continued its share buyback programme, purchasing 198,675 ordinary shares at 362.13 pence each, which will be held in treasury. Following this transaction, the trust now holds 218,339,620 shares in treasury out of a total 601,665,200 shares in issue, reducing the number of voting rights to 383,325,580, a key figure for shareholders assessing disclosure obligations under FCA transparency rules and signalling ongoing capital management efforts that can support net asset value and share price alignment.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Business Operations and StrategyStock Buyback
Worldwide Healthcare Trust Extends Share Buyback Programme
Positive
Feb 4, 2026

The trust repurchased 350,000 ordinary shares at 362.88 pence each for treasury, taking treasury holdings to 218.1 million shares and reducing voting rights in issue to 383.5 million; the updated denominator helps investors track disclosure thresholds and signals continued use of its buyback mandate to manage capital and support share price discipline.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Regulatory Filings and Compliance
Worldwide Healthcare Trust Confirms Updated Total Voting Rights
Neutral
Feb 2, 2026

Worldwide Healthcare Trust PLC reported that as of 31 January 2026 its issued share capital comprises 601,665,200 ordinary shares of 2.5p each, of which 217,790,945 are held in treasury. This leaves a total of 383,874,255 voting rights in the company, a key reference figure for shareholders assessing whether their holdings trigger disclosure obligations under UK Financial Conduct Authority transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Buys Back 600,000 Shares for Treasury
Neutral
Jan 30, 2026

Worldwide Healthcare Trust PLC has continued to execute its share buyback programme, repurchasing 600,000 ordinary shares of 2.5p each at a price of 362.34 pence per share, with the shares being placed into treasury rather than cancelled. Following this transaction, the trust now holds 217,790,945 shares in treasury and has 601,665,200 ordinary shares in issue, resulting in 383,874,255 voting rights, a figure shareholders are advised to use when assessing disclosure obligations under the FCA’s transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Expands Treasury Stock with Purchase of 400,000 Shares
Neutral
Jan 28, 2026

Worldwide Healthcare Trust PLC has executed a market purchase of 400,000 of its own ordinary shares at 368.47 pence per share, with the shares to be held in treasury under a previously granted authority allowing buybacks up to 61,086,622 shares. Following this transaction, the company now holds 217,190,945 shares in treasury and has 601,665,200 ordinary shares in issue, resulting in 384,474,255 voting rights outstanding, a figure shareholders are advised to use when assessing whether they must notify changes in their holdings under FCA disclosure rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Increases Treasury Stock After Share Buyback
Neutral
Jan 23, 2026

Worldwide Healthcare Trust PLC has repurchased 35,138 of its own ordinary shares at 376.06 pence per share, with the shares to be held in treasury as part of its ongoing buyback programme authorised by shareholders in October 2025. Following this transaction, treasury shares have risen to 216,790,945, leaving 601,665,200 ordinary shares in issue and total voting rights of 384,874,255, a change that affects share capital structure and provides an updated denominator for investors monitoring their disclosure obligations under UK transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Business Operations and StrategyStock Buyback
Worldwide Healthcare Trust Buys Back 850,000 Shares for Treasury
Neutral
Jan 21, 2026

Worldwide Healthcare Trust PLC has executed a market buyback of 850,000 ordinary shares at 374.16 pence per share, with the repurchased shares to be held in treasury. Following this transaction, the trust now holds 216,755,807 shares in treasury and has 601,665,200 ordinary shares in issue, resulting in 384,909,393 voting rights in the company, a key figure for shareholders monitoring disclosure thresholds under FCA rules; the move reflects ongoing use of its shareholder-approved buyback authority, which can support share price and capital management objectives.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Regulatory Filings and Compliance
Worldwide Healthcare Trust Director Adds Shares Through Dividend Reinvestment
Neutral
Jan 20, 2026

Worldwide Healthcare Trust PLC has disclosed that non-executive director Timothy James Livett acquired 39 ordinary 2.5p shares in the company via a dividend reinvestment on 9 January 2026 at a price of 388.698 pence per share on the London Stock Exchange. The modest share purchase, executed under a dividend reinvestment plan, signals ongoing alignment of the director’s interests with shareholders and complies with regulatory requirements for transparency in transactions by persons discharging managerial responsibilities.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Buys Back 450,000 Shares for Treasury
Positive
Jan 16, 2026

Worldwide Healthcare Trust PLC has executed a share buyback, purchasing 450,000 ordinary shares at 377.78 pence each to be held in treasury under its existing authority to repurchase up to 61,086,622 shares. Following this transaction, the trust now holds 215,905,807 shares in treasury, with 601,665,200 shares in issue and 385,759,393 voting rights outstanding, a structure that may enhance net asset value per share and is relevant for shareholders monitoring their disclosure thresholds under FCA transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Financial Disclosures
Worldwide Healthcare Trust to Publish December 2025 Monthly Fact Sheet
Neutral
Jan 16, 2026

Worldwide Healthcare Trust PLC has announced that its monthly fact sheet for 31 December 2025 will shortly be available on the company’s website, providing updated portfolio and performance information to investors. The release underlines the trust’s ongoing commitment to transparency and regular disclosure, giving shareholders and prospective investors timely data to assess its positioning and performance in the global healthcare investment space.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £397.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Boosts Treasury Stock With New Share Buyback
Positive
Jan 14, 2026

Worldwide Healthcare Trust PLC, a UK-listed healthcare-focused investment trust, has continued its active capital management programme by repurchasing 708,683 ordinary shares at 380.32 pence per share for holding in treasury, under the authority granted by shareholders in October 2025. Following this transaction, the trust now holds 215,455,807 shares in treasury and has 601,665,200 shares in issue, resulting in 386,209,393 voting rights outstanding, a figure shareholders must now use when assessing disclosure obligations under FCA transparency rules; the move may support the share price and enhance net asset value per share for remaining investors by reducing the free float.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £373.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Boosts Treasury Stock With New Share Buyback
Neutral
Jan 9, 2026

Worldwide Healthcare Trust PLC has repurchased 412,779 of its own ordinary shares at 388.96 pence per share under its existing buyback authority, and will hold the shares in treasury. Following this transaction, the company holds 214,747,124 shares in treasury, has 601,665,200 ordinary shares in issue, and reports 386,918,076 voting rights in total, a figure shareholders are advised to use when assessing their disclosure obligations under FCA transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £385.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Corrects Treasury Share and Voting Rights Figures After Buyback
Neutral
Jan 8, 2026

Worldwide Healthcare Trust PLC has issued a correction to a prior announcement regarding its latest share buyback, clarifying the precise number of shares held in treasury and the total voting rights outstanding. The company repurchased 501,277 ordinary shares at 376.51 pence each, to be held in treasury, bringing its treasury holding to 214,334,345 shares and leaving 387,330,855 shares with voting rights out of 601,665,200 shares in issue. The updated voting rights figure is significant for shareholders and investors, as it serves as the reference denominator for regulatory disclosures under the FCA’s transparency rules and reflects the ongoing execution of the company’s approved share repurchase programme.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £385.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Increases Treasury Stock After Share Buyback
Neutral
Jan 7, 2026

Worldwide Healthcare Trust PLC has executed a market buyback of 501,277 ordinary shares at 376.51 pence per share, with the repurchased stock to be held in treasury. Following this transaction, the trust now holds 214,334,295 shares in treasury, has 601,665,200 shares in issue, and a total of 387,330,905 voting rights, a figure shareholders are advised to use when assessing disclosure obligations under FCA transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £385.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Regulatory Filings and Compliance
Worldwide Healthcare Trust Confirms Updated Total Voting Rights
Neutral
Jan 2, 2026

Worldwide Healthcare Trust PLC has confirmed its total voting rights as at 31 December 2025, stating that its share capital comprises 601,665,200 ordinary shares of 2.5p each, of which 213,833,068 are held in Treasury. This leaves 387,832,132 ordinary shares carrying voting rights, a figure that shareholders are expected to use as the denominator when assessing whether they must notify the regulator of changes in their holdings under the Financial Conduct Authority’s disclosure and transparency rules, providing clarity on the company’s capital structure and regulatory reporting obligations for investors.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £385.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Worldwide Healthcare Trust Buys Back 500,000 Shares for Treasury
Neutral
Dec 30, 2025

Worldwide Healthcare Trust PLC has continued to execute its share buyback programme, purchasing 500,000 ordinary shares at 377.15 pence each for holding in treasury under authority granted by shareholders in October 2025. Following this transaction, the trust now holds 213,833,068 shares in treasury, with 601,665,200 shares in issue and 387,832,132 voting rights in circulation, a figure shareholders are advised to use when assessing disclosure thresholds under the FCA’s transparency rules.

The most recent analyst rating on (GB:WWH) stock is a Hold with a £385.00 price target. To see the full list of analyst forecasts on Worldwide Healthcare Trust PLC GBP stock, see the GB:WWH Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025